| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 18.44B | 17.68B | 15.64B | 17.52B | 20.03B | 18.34B |
| Gross Profit | 10.57B | 10.08B | 9.09B | 11.02B | 13.77B | 12.38B |
| EBITDA | 8.26B | 8.25B | 7.54B | 9.01B | 11.22B | 10.06B |
| Net Income | 5.37B | 5.00B | 4.80B | 6.51B | 8.75B | 7.77B |
Balance Sheet | ||||||
| Total Assets | 34.39B | 34.59B | 35.51B | 32.35B | 27.21B | 24.68B |
| Cash, Cash Equivalents and Short-Term Investments | 5.10B | 4.88B | 7.58B | 8.57B | 9.07B | 9.74B |
| Total Debt | 14.05B | 15.39B | 15.04B | 12.27B | 9.50B | 8.21B |
| Total Liabilities | 17.61B | 18.31B | 18.61B | 15.45B | 12.63B | 11.34B |
| Stockholders Equity | 16.78B | 16.27B | 16.90B | 16.90B | 14.58B | 13.33B |
Cash Flow | ||||||
| Free Cash Flow | 3.72B | 2.60B | 1.50B | 1.35B | 5.92B | 6.29B |
| Operating Cash Flow | 7.82B | 7.15B | 6.32B | 6.42B | 8.72B | 8.76B |
| Investing Cash Flow | -2.74B | -1.44B | -3.20B | -4.36B | -3.58B | -4.09B |
| Financing Cash Flow | -4.30B | -5.69B | -2.88B | -2.14B | -6.72B | -3.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
84 Outperform | $842.20B | 8.48 | 40.84% | 0.20% | 85.55% | 410.18% | |
80 Outperform | $226.92B | 177.55 | 11.86% | ― | 22.79% | 12.94% | |
77 Outperform | $203.35B | 45.73 | 7.92% | 1.43% | 25.91% | 74.58% | |
74 Outperform | $261.92B | 28.56 | 32.49% | 3.11% | 14.89% | 10.49% | |
71 Outperform | $230.92B | 4.59 | 40.19% | 2.01% | 5.21% | -6.72% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | $627.85B | -14.70 | -2.95% | ― | 1.36% | 86.07% |